Aro Biotherapeutics has a total of 41 patents globally, out of which 2 have been granted. Of these 41 patents, more than 82% patents are active. The United States of America is where Aro Biotherapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Aro Biotherapeutics.
Aro Biotherapeutics was founded in 2017. Aro Biotherapeutics is a biotechnology company that specializes in the investigation and creation of novel protein biologics. It offers services in the areas of oncology, siRNA, immunology, bispecific, protein conjugation, protein therapies, licensing, drug delivery, and protein engineering.
Do read about some of the most popular patents of Aro Biotherapeutics which have been covered by us in this article and also you can find Aro Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aro Biotherapeutics patent portfolio.
How many patents does Aro Biotherapeutics have?
Aro Biotherapeutics has a total of 41 patents globally. These patents belong to 11 unique patent families. Out of 41 patents, 34 patents are active.
How Many Patents did Aro Biotherapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Aro Biotherapeutics Applications Filed | Aro Biotherapeutics Patents Granted |
| 2023 | 6 | 2 |
| 2022 | 14 | – |
| 2021 | 6 | – |
| 2020 | 15 | – |
How many Aro Biotherapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Aro Biotherapeutics File in Different Countries?
Countries in which Aro Biotherapeutics Filed Patents
| Country | Patents |
| United States Of America | 7 |
| Australia | 4 |
| Canada | 4 |
| Hong Kong (S.A.R.) | 4 |
| China | 3 |
| Europe | 3 |
| New Zealand | 3 |
| South Africa | 2 |
| Taiwan | 2 |
Where are Research Centers of Aro Biotherapeutics Patents Located?
10 Best Aro Biotherapeutics Patents
US11628222B2, US20220332795A1 are the most popular patents in the Aro Biotherapeutics portfolio they have received 1 citation.
List of Aro Biotherapeutics patents
| Aro Biotherapeutics Patents | Title |
| US11781138B2 | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| US11628222B2 | Cd71 Binding Fibronectin Type Iii Domains |
| US20230330239A1 | Epcam Binding Fibronectin Type Iii Domains |
| US20230183314A1 | Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same |
| US20230039851A1 | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| US20220370626A1 | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| US20220332795A1 | Cd71 Binding Fibronectin Type Iii Domains |
| EP4146805A2 | Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same |
| EP4076505A1 | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| EP4045061A1 | Cd71 Binding Fibronectin Type Iii Domains |
| CN115884778A | Fibronectin Type Iii Domains Binding To Prostate-Specific Membrane Antigens And Cells Comprising Same |
| CN115175691A | Serum Albumin Binding Fibronectin Type Iii Domains And Uses Thereof |
| CN114786682A | Fibronectin Type Iii Domains That Bind Cd71 |
| WO2023201362A2 | Fn3 Domain-Sirna Conjugates With Enzyme Replacement Therapy |
| WO2023003874A3 | Human Fibronectin Type Iii Protein Scaffolds |
| CA3214552A1 | Cd71 Binding Fibronectin Type Iii Domains |
| CA3215367A1 | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| CA3177330A1 | Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same |
| CA3161723A1 | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| AU2022258584A1 | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| AU2022258566A1 | Cd71 Binding Fibronectin Type Iii Domains |
| AU2021266735A1 | Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same |
| AU2020405107A1 | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| ZA202309758A | Cd71 Binding Fibronectin Type Iii Domains |
| ZA202309611A | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| HK40083231A | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| HK40081011A | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| HK40079223A | Cd71 Binding Fibronectin Type Iii Domains |
| HK40076447A | Cd71 Binding Fibronectin Type Iii Domains |
| TW202304519A | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| TW202304971A | Cd71 Binding Fibronectin Type Iii Domains |
| NZ804071A | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| NZ804153A | Cd71 Binding Fibronectin Type Iii Domains |
| NZ789645A | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| WO2022221505A3 | Cd71 Binding Fibronectin Type Iii Domains |
| WO2022221550A1 | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| WO2021226223A3 | Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same |
| WO2021127353A1 | Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof |
| WO2021076546A9 | Cd71 Binding Fibronectin Type Iii Domains |
| WO2021076574A3 | Fn3 Domain-Sirna Conjugates And Uses Thereof |
| WO2021076543A1 | Epcam Binding Fibronectin Type Iii Domains |
What are Aro Biotherapeutics key innovation segments?
What Technologies are Covered by Aro Biotherapeutics?
The chart below distributes patents filed by Aro Biotherapeutics